The largest database of trusted experimental protocols

2 protocols using β tubulin e7

1

Enhancing Oncolytic Virus Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with combinations of non-targeting (NT), Receptor Interacting Protein1 (RIP1), Caspase-8 (CASP8), TNF-R1, and DR5 small interfering RNA (siRNA) (ON-Target SmartPool, Thermo Fisher Scientific) for 48 hr. Cells were then treated with vehicle or 5 μM LCL161 and infected with the indicated OV. Cell viability was assessed by Alamar blue. Knockdown of TNF-R1 and DR5 was determined by western blotting using the following antibodies: RIP1 (D94C12; Cell Signaling Technology), CASP8 (AF705), DR5 (3696; Cell Signaling Technology), TNF-R1 (3736; Cell Signaling Technology), β-tubulin (E7; Developmental Studies Hybridoma Bank), and GAPDH (GAPDH-71.1; Sigma). For antibody-mediated neutralization of TNF-α, cells were treated with 50 μg/mL of mouse immunoglobulin G (IgG) control (HRPN; BioXCell) or anti-TNF-α (XT3.11; BioXCell). One hour later, cells were treated with vehicle or 5 μM LCL161 and the indicated MOI of OV. Cell viability was assessed by Alamar blue.
+ Open protocol
+ Expand
2

Western Blot Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies used were: Anti-DDK (FLAG) (Origene, TA50011), Phospho-Y705-STAT3, STAT3, GFP (Cell Signaling Technology, #9145, #9139, and #2956), and β-tubulin E7 (Developmental Studies Hybridoma Bank) and infrared secondary antibodies from LI-COR (IRDye 800CW Donkey anti-Rabbit IgG and IRDye 680LT Donkey anti-Mouse IgG). Blots were developed and quantified on a LI-COR Odyssey Classic.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!